Advertisement

Measures of Potential Impact

  • David G. Kleinbaum
  • Kevin M. Sullivan
  • Nancy D. Barker
Chapter

Abstract

In the previous lesson on Measures of Effect, we focused exclusively on ratio measures of effect. In this lesson, we consider difference measures of effect and other related measures that allow the investigator to consider the potential public health impact of the results obtained from an epidemiologic study.

Keywords

Risk Ratio Cumulative Incidence Excess Risk Prevent Fraction Risk Difference 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Benichou J, Chow WH, McLaughlin JK, Mandel JS, and Fraumeni JF Jr. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 1988;148(5):424-30.CrossRefGoogle Scholar
  2. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310(6977):452-4.CrossRefGoogle Scholar
  3. Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR. Medical Epidemiology (3rd Ed). Lange Medical Books, New York, 2001.Google Scholar
  4. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132(4):270-8.Google Scholar
  5. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. John Wiley and Sons Publishers, New York, 1982.Google Scholar
  6. Landrigan PJ, Epidemic measles in a divided city. JAMA 1972;221(6):567-70.CrossRefGoogle Scholar
  7. Medical Research Council trial of treatment of mild hypertension: principal results. MRC Working Party. BMJ 1985:291;97-104.Google Scholar
  8. Morgenstern H and Bursic ES,. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health 1982;7(4):292-309.CrossRefGoogle Scholar
  9. Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med 1994;51(12):804-11.CrossRefGoogle Scholar
  10. Wacholder S, Benichou J, Heineman EF, Hartge P, Hoover RN. Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol 1994;140(4):303-9..Google Scholar
  11. Walter SD. Calculation of attributable risks from epidemiological data. Int J Epidemiol 1978;7(2):175-82.CrossRefGoogle Scholar
  12. Walter SD. Prevention for multifactorial diseases. Am J Epidemiol 1980;112(3):409-16.Google Scholar
  13. Walter SD. Attributable risk in practice. Am J Epidemiol 1998;148(5):411-3.CrossRefGoogle Scholar
  14. Walter SD. Number needed to treat (NNT): estimation of a measure of clinical benefit. Stat Med 2001:20(24);3947-62.CrossRefGoogle Scholar
  15. Wilson PD, Loffredo CA, Correa-Villasenor A, Ferencz C. Attributable fraction for cardiac malformations. Am J Epidemiol 1998;148(5):414-23.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • David G. Kleinbaum
    • 1
  • Kevin M. Sullivan
    • 2
  • Nancy D. Barker
    • 3
  1. 1.Rollins School of Public HealthEmory UniversityAtlantaUSA
  2. 2.Department of Epidemiology Rollins School of Public HealthEmory UniversityAtlantaUSA
  3. 3.AlpharettaUSA

Personalised recommendations